Nov 17, 2021 / 01:45PM GMT
Timothy Minton Anderson - Wolfe Research, LLC - MD of Equity Research
Okay. Well, good morning and thank you to everyone for joining us to our Wolfe health care conference that runs today and tomorrow. We have a host of companies from my coverage, from Justin Lake's coverage, from Andrew Galler's coverage. And most of these sessions will be fireside chats. And we're going to kick things off this morning with Giovanni Caforio. He's the Chairman and CEO of Bristol-Myers Squibb. He has been with the company for quite some time, I think since 2000. And in case you missed it yesterday, the company held a very comprehensive Analyst Day, running through many aspects of the business, pipeline, key marketed products, future patent expiries, what Bristol is trying to do to stay [relevant]. And there was a lot of content. So why don't we start with some general questions, Giovanni?
Questions and Answers:
Timothy Minton Anderson - Wolfe Research, LLC - MD of Equity ResearchSo 2021 is coming to an end, just 6 weeks left. How is the setup for 2022 looking for Bristol?